Skip to main content
. 2016 Feb 24;7(12):15262–15273. doi: 10.18632/oncotarget.7683

Table 2. Pooled hazard ratios for overall survival and recurrence-free survival.

Pooled analysis Study number HR (95% CI) P for difference P for heterogeneity and I-squared
Overall Survival
All groups 15 0.853 (0.741-0.981) 0.026 0.001 and 61.3%
In colorectal cancer 5 0.653 (0.430-0.991) 0.045 0.038 and 60.6%
In prostate cancer 3 1.194 (0.735-1.941) 0.474 0.085 and 59.5%
Recurrence-free Survival
All groups 19 0.846 (0.718-0.998) 0.047 0.000 and 71.4%
In prostate cancer 7 0.919 (0.765-1.104) 0.366 0.127 and 39.7%
In ovarian cancer 3 0.640 (0.396-1.033) 0.068 0.133 and 50.4%